BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 24894541)

  • 1. Impact of self-reported gastroesophageal reflux disease in subjects from COPDGene cohort.
    Martinez CH; Okajima Y; Murray S; Washko GR; Martinez FJ; Silverman EK; Lee JH; Regan EA; Crapo JD; Curtis JL; Hatabu H; Han MK;
    Respir Res; 2014 Jun; 15(1):62. PubMed ID: 24894541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of gastroesophageal reflux on longitudinal lung function and quantitative computed tomography in the COPDGene cohort.
    Baldomero AK; Wendt CH; Petersen A; Gaeckle NT; Han MK; Kunisaki KM;
    Respir Res; 2020 Aug; 21(1):203. PubMed ID: 32746820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy with proton-pump inhibitors for gastroesophageal reflux disease does not reduce the risk for severe exacerbations in COPD.
    Baumeler L; Papakonstantinou E; Milenkovic B; Lacoma A; Louis R; Aerts JG; Welte T; Kostikas K; Blasi F; Boersma W; Torres A; Rohde GG; Boeck L; Rakic J; Scherr A; Tamm M; Stolz D
    Respirology; 2016 Jul; 21(5):883-90. PubMed ID: 26970108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for COPD exacerbations in inhaled medication users: the COPDGene study biannual longitudinal follow-up prospective cohort.
    Busch R; Han MK; Bowler RP; Dransfield MT; Wells JM; Regan EA; Hersh CP;
    BMC Pulm Med; 2016 Feb; 16():28. PubMed ID: 26861867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton pump inhibitors for chronic obstructive pulmonary disease.
    Kikuchi S; Imai H; Tani Y; Tajiri T; Watanabe N
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013113. PubMed ID: 32844430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newly diagnosed gastroesophageal reflux disease increased the risk of acute exacerbation of chronic obstructive pulmonary disease during the first year following diagnosis--a nationwide population-based cohort study.
    Lin YH; Tsai CL; Chien LN; Chiou HY; Jeng C
    Int J Clin Pract; 2015 Mar; 69(3):350-7. PubMed ID: 25359162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between chronic obstructive pulmonary disease and gastroesophageal reflux disease: a national cross-sectional cohort study.
    Kim J; Lee JH; Kim Y; Kim K; Oh YM; Yoo KH; Rhee CK; Yoon HK; Kim YS; Park YB; Lee SW; Lee SD
    BMC Pulm Med; 2013 Aug; 13():51. PubMed ID: 23927016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective evaluation of the relationship between acute exacerbations of COPD and gastroesophageal reflux disease diagnosed by questionnaire.
    Takada K; Matsumoto S; Kojima E; Iwata S; Okachi S; Ninomiya K; Morioka H; Tanaka K; Enomoto Y
    Respir Med; 2011 Oct; 105(10):1531-6. PubMed ID: 21454063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of gastroesophageal reflux disease risk with exacerbations of chronic obstructive pulmonary disease.
    Liang B; Wang M; Yi Q; Feng Y
    Dis Esophagus; 2013 Aug; 26(6):557-60. PubMed ID: 23301861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of gastroesophageal reflux symptoms in exacerbations of COPD.
    Rascon-Aguilar IE; Pamer M; Wludyka P; Cury J; Coultas D; Lambiase LR; Nahman NS; Vega KJ
    Chest; 2006 Oct; 130(4):1096-101. PubMed ID: 17035443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing decline in quality of life in smokers without airflow obstruction: The COPDGene study.
    Parekh TM; Bhatia S; Cherrington A; Kim YI; Lambert A; Iyer A; Regan EA; DeMeo DL; Han M; Dransfield MT
    Respir Med; 2020 Jan; 161():105820. PubMed ID: 31759270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of five clusters of comorbidities in a longitudinal Japanese chronic obstructive pulmonary disease cohort.
    Chubachi S; Sato M; Kameyama N; Tsutsumi A; Sasaki M; Tateno H; Nakamura H; Asano K; Betsuyaku T;
    Respir Med; 2016 Aug; 117():272-9. PubMed ID: 27492541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunostimulants versus placebo for preventing exacerbations in adults with chronic bronchitis or chronic obstructive pulmonary disease.
    Fraser A; Poole P
    Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013343. PubMed ID: 36373977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The St. George's Respiratory Questionnaire Definition of Chronic Bronchitis May Be a Better Predictor of COPD Exacerbations Compared With the Classic Definition.
    Kim V; Zhao H; Regan E; Han MK; Make BJ; Crapo JD; Jones PW; Curtis JL; Silverman EK; Criner GJ;
    Chest; 2019 Oct; 156(4):685-695. PubMed ID: 31047955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of comorbidities on COPD-specific health-related quality of life.
    Burgel PR; Escamilla R; Perez T; Carré P; Caillaud D; Chanez P; Pinet C; Jebrak G; Brinchault G; Court-Fortune I; Paillasseur JL; Roche N;
    Respir Med; 2013 Feb; 107(2):233-41. PubMed ID: 23098687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Factors for Chronic Obstructive Pulmonary Disease Exacerbations among Individuals without a History of Recent Exacerbations: A COPDGene Analysis.
    Ferrera MC; Lopez CL; Murray S; Jain RG; Labaki WW; Make BJ; Han MK
    Ann Am Thorac Soc; 2024 Mar; 21(3):421-427. PubMed ID: 37796613
    [No Abstract]   [Full Text] [Related]  

  • 17. Proton pump inhibitors use is associated with a lower risk of acute exacerbation and mortality in patients with coexistent COPD and GERD.
    Su VY; Liao HF; Perng DW; Chou YC; Hsu CC; Chou CL; Chang YL; Yen JC; Chen TJ; Chou TC
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2907-2915. PubMed ID: 30275689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between gastroesophageal reflux disease and COPD in UK primary care.
    García Rodríguez LA; Ruigómez A; Martín-Merino E; Johansson S; Wallander MA
    Chest; 2008 Dec; 134(6):1223-1230. PubMed ID: 18689591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does gastroesophageal reflux increase chronic obstructive pulmonary disease exacerbations?
    Iliaz S; Iliaz R; Onur ST; Arici S; Akyuz U; Karaca C; Demir K; Besisik F; Kaymakoglu S; Akyuz F
    Respir Med; 2016 Jun; 115():20-5. PubMed ID: 27215499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of thrombocytosis with COPD morbidity: the SPIROMICS and COPDGene cohorts.
    Fawzy A; Putcha N; Paulin LM; Aaron CP; Labaki WW; Han MK; Wise RA; Kanner RE; Bowler RP; Barr RG; Hansel NN;
    Respir Res; 2018 Jan; 19(1):20. PubMed ID: 29373977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.